HSP90AA1 and Alzheimer disease: On the other hand, AD patients using systemic treatment (e.g., phototherapy, systemic corticosteroids, cyclosporine, methotrexate, azathioprine, JAK inhibitors, and biologics) that could potentially influence the Hsp90 content in the blood were excluded from the study.